NYSE: MRKMerck & Co Inc Stock
$88.39+0.00 (+0%)
Updated Oct 5, 2022
MRK Price
$88.39
Fair Value Price
N/A
Market Cap
$223.92B
52 Week Low
$71.50
52 Week High
$95.72
P/E
13.47x
P/B
5.18x
P/S
4.03x
PEG
1.79x
Dividend Yield
3.12%
Revenue
$57.17B
Earnings
$16.58B
Gross Margin
70.4%
Operating Margin
32.27%
Profit Margin
29%
Debt to Equity
1.48
Operating Cash Flow
$19B
Beta
0.57
Next Earnings
Oct 27, 2022
Ex-Dividend
Sep 14, 2022
Next Dividend
Oct 7, 2022
Zen Score
–
Industry Average (49)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MRK scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MRK ($88.39) is trading below its intrinsic value of $173.24, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MRK is good value based on its earnings relative to its share price (13.47x), compared to the US market average (28.61x)
P/E vs Market Valuation
MRK is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more MRK due diligence checks available for Premium users.
Be the first to know about important MRK news, forecast changes, insider trades & much more!
MRK News
Valuation
MRK price to earnings (PE)
For valuing profitable companies with steady earnings
Company
13.47x
Industry
12.64x
Market
28.61x
MRK is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MRK is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
MRK price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
5.18x
Industry
4.84x
MRK is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MRK price to earnings growth (PEG)
For valuing profitable companies with growth potential
MRK is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
MRK's financial health
Profit margin
Revenue
$14.6B
Net Income
$3.9B
Profit Margin
27%
MRK's Earnings (EBIT) of $18.45B... subscribe to Premium to read more.
Interest Coverage Financials
MRK's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$107.1B
Liabilities
$63.8B
Debt to equity
1.48
MRK's short-term assets ($32.12B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MRK's long-term liabilities ($40.61B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MRK's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
MRK's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$4.3B
Investing
-$1.1B
Financing
-$1.8B
MRK's operating cash flow ($18.89B)... subscribe to Premium to read more.
Debt Coverage Financials
MRK vs General Drug Manufacturer Stocks
Merck & Co Stock FAQ
©2022 WallStreetZen
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.